Bioneer, a leading biotechnology company with over 30 years of expertise in molecular and synthetic biology, announced on May 26 that it has developed a new gene synthesis technology capable of precisely synthesizing and assembling DNA sequences up to 100 kilobases (100kb) in length. This breakthrough technology focuses on accurately synthesizing up to 100,000 base […]
The deal will advance global research in key areas such as drug discovery, development, toxicology, and personalized medicine WESTBURY, N.Y. — BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced an exclusive commercial agreement with Handok Biotech Co. LTD., which will allow Handok to offer researchers in South […]
New capital from Supernova Invest, alongside existing partners Elaia, Omnes, and Merieux Equity Partners, will accelerate SeqOne’s mission to transform genomic diagnostics worldwide, focusing on international expansion, U.S., and strategic growth. MONTPELLIER, France – SeqOne, a pioneer in AI-driven genomic analysis for personalized medicine, today announced a significant €20 million oversubscribed growth funding round. Led by […]
The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche’s SBX sequencing technology1, with an initial focus on critically ill newborns and their parents. Whole genome sequencing can help diagnose babies with suspected genetic disorders, such as cystic fibrosis and sickle cell disease. This project will explore how this technology could […]
New capital from Supernova Invest, alongside existing partners Elaia, Omnes, and Merieux Equity Partners, will accelerate SeqOne’s mission to transform genomic diagnostics worldwide, focusing on international expansion, U.S., and strategic growth. SeqOne, a pioneer in AI-driven genomic analysis for personalized medicine, today announced a significant €20 million oversubscribed growth funding round. Led by new investor […]
Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for cancer research Combines QIAGEN’s global reach and automation expertise with ID Solutions’ assay development for research purposes and manufacturing strengths VENLO, Netherlands — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a new commercial partnership […]
The new facility will integrate the full chain of resources to accelerate new product launches, enable customized development, and better serve the Chinese market. The opening of the new headquarters will strengthen the collaboration of local team and capabilities, enabling even stronger alignment with Esco’s global expertise. SHANGHAI – Esco Lifesciences Group is proud to announce […]
Shimadzu Corporation invested in Persist AI Formulation Corp (Persist AI, based in California) through the Corporate Venture Capital (CVC) fund “Shimadzu Future Innovation Fund” (Shimadzu FIF). The company is developing a platform that utilizes AI and robotics to streamline the formulation of pharmaceuticals. The formulation process, which involves processing the pharmaceutical active ingredients into useful […]
Haorui’s established footprint brings HiFi sequencing to new customers including hospital labs and regional blood centers MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized leader in blood typing genomics, as an official distributor in China. The distribution […]
Offer end-to-end workflow from library prep through sequencing Twist to be sole provider of new Trinity™ library prep and target enrichment kits for Element AVITI™ sequencer Joint commercial activities to expand customer access to new NGS tools SOUTH SAN FRANCISCO, Calif. & SAN DIEGO — Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
